Logo do repositório
 
A carregar...
Miniatura
Publicação

High levels of physical activity reduce the esthetic durability of botulinum toxin type A : a controlled single-blind clinical trial

Utilize este identificador para referenciar este registo.
Nome:Descrição:Tamanho:Formato: 
Artigo_GDeLaTorreCanales_2023_02.pdf559.52 KBAdobe PDF Ver/Abrir

Orientador(es)

Resumo(s)

The present study aimed to evaluate the influence of physical activity on the durability of the esthetic effect of botulinum toxin type A (BoNT-A). Sixty female patients were allocated to three groups (n = 20) according to their physical activity level (PA): Low PA, Moderate PA, and High PA. All groups received a single injection of onabotulinumtoxinA, considering standardized doses in the frontalis (12U), corrugator supercilia (7U, each), and procerus muscles (4U). Outcomes were measured using electromyography (EMG), Merz 5-point scales, and Face-Q scales (perceived age and lines between eyebrows). A follow-up occurred after 30, 60, and 90 days. EMG results showed a significant decrease in muscle activity in the Low-PA group at all follow-ups compared with the other groups (p < 0.001). The Merz scale scores showed that the severity of forehead and glabellar lines significantly improved in the Low-PA group throughout this study compared with the other groups (p < 0.001). No significant differences between groups were found in the Face-Q scale for perceived age, while the Face-Q scale for lines between eyebrows showed better results for Low-PA (p < 0.01) and Moderate-PA (p < 0.01) groups compared to the High-PA group at the 30- and 90-day follow-ups. The durability of the esthetic effect of BoNT-A seems to be negatively influenced by the level of physical activity.

Descrição

Palavras-chave

botulinum toxin electromyography physical activity wrinkles

Contexto Educativo

Citação

Morhy ON, Sisnando AL, Câmara-Souza MB, Carbone AC, De la Torre Canales G. High Levels of Physical Activity Reduce the Esthetic Durability of Botulinum Toxin Type A: A Controlled Single-Blind Clinical Trial. Toxins. 2023; 15(7):463. https://doi.org/10.3390/toxins15070463

Projetos de investigação

Unidades organizacionais

Fascículo

Editora

MDPI

Licença CC

Métricas Alternativas